Lux Co-invest Opportunities, L.p. - Net Worth and Insider Trading
Lux Co-invest Opportunities, L.p. Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Lux Co-invest Opportunities, L.p. owns 6 companies in total, including Recursion Pharmaceuticals Inc (RXRX) , Aeva Technologies Inc (AEVA) , and Science 37 Holdings Inc (SNCE) among others .
Insider Ownership Summary of Lux Co-invest Opportunities, L.p.
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
RXRX | Recursion Pharmaceuticals Inc | 2021-12-07 | other: Former 10% Owner |
AEVA | Aeva Technologies Inc | 2021-03-12 | 10 percent owner |
SNCE | Science 37 Holdings Inc | 2021-10-06 | 10 percent owner |
2021-07-22 | 10 percent owner | ||
2021-06-04 | 10 percent owner | ||
2021-06-04 | 10 percent owner |
Lux Co-invest Opportunities, L.p. Trading Performance
Lux Co-invest Opportunities, L.p. Ownership Network
Ownership Network List of Lux Co-invest Opportunities, L.p.
Ownership Network Relation of Lux Co-invest Opportunities, L.p.
Lux Co-invest Opportunities, L.p. Owned Company Details
What does Recursion Pharmaceuticals Inc do?
Who are the key executives at Recursion Pharmaceuticals Inc?
Lux Co-invest Opportunities, L.p. is the other: Former 10% Owner of Recursion Pharmaceuticals Inc. Other key executives at Recursion Pharmaceuticals Inc include President and COO Tina Marriott Larson , Chief Financial Officer Michael Secora , and director & 10 percent owner & Chief Executive Officer Christopher Gibson .
Recursion Pharmaceuticals Inc (RXRX) Insider Trades Summary
Over the past 18 months, Lux Co-invest Opportunities, L.p. made no insider transaction in Recursion Pharmaceuticals Inc (RXRX). Other recent insider transactions involving Recursion Pharmaceuticals Inc (RXRX) include a net sale of 496,133 shares made by Blake Borgeson , a net sale of 1,209,278 shares made by Christopher Gibson , and a net sale of 94,000 shares made by Tina Marriott Larson .
In summary, during the past 3 months, insiders sold 256,682 shares of Recursion Pharmaceuticals Inc (RXRX) in total and bought 0 shares, with a net sale of 256,682 shares. During the past 18 months, 2,974,541 shares of Recursion Pharmaceuticals Inc (RXRX) were sold and 0 shares were bought by its insiders, resulting in a net sale of 2,974,541 shares.
Recursion Pharmaceuticals Inc (RXRX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Recursion Pharmaceuticals Inc Insider Transactions
Lux Co-invest Opportunities, L.p. Mailing Address
Above is the net worth, insider trading, and ownership report for Lux Co-invest Opportunities, L.p.. You might contact Lux Co-invest Opportunities, L.p. via mailing address: C/o Lux Capital Management, 920 Broadway, 11th Floor, New York Ny 10010.